IMCD, NL0010801007

IMCD reported first-half EBITA up 4 percent: IMCD stock falls 1.79 percent

Published on 10/15/2026 at 15:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
First-half revenue rose 6.6 percent to EUR 2.65 billion. IMCD stock costs EUR 102.83 on October 15, 2026, down 1.79 percent versus Tradegate close.

Financial results and trading

  • IMCD reported first-half EBITA of EUR 285 million, up 4 percent, on July 29, 2026.
  • First-half 2026 revenue reached EUR 2.65 billion, up 6.6 percent year on year.
  • IMCD stock costs EUR 102.83 at Lang & Schwarz on October 15, 2026 at 3:02 p.m. CEST, 1.79 percent below the Tradegate close of October 14, 2026.
  • IMCD will publish its first nine months 2026 results on November 5, 2026.
Flatlay-Arrangement mit ISIN-Karte NL0010801007 repräsentiert Aktie von IMCD N.V. neben Chemie- und Gewürzproben, Illustration mit AI erstellt.

IMCD reported first-half EBITA of EUR 285 million, up 4 percent from the prior-year period, according to GlobeNewswire, which carries IMCD's July 29, 2026 results release. IMCD stock was trading at EUR 102.83 at Lang & Schwarz on October 15, 2026 at 3:02 p.m. CEST, down 1.79 percent versus the Tradegate close of October 14, 2026 at EUR 104.70.

Revenue supports the earnings picture

First-half 2026 revenue reached EUR 2.65 billion, a 6.6 percent increase from the first half of 2025, according to Simply Wall St. The same period produced earnings per share of EUR 2.41, compared with EUR 2.20 in the first half of 2025.

The operating result gives the stock a concrete earnings anchor after its strong recovery from the 2025 decline. The reported first-half EBITA growth was 4 percent, while revenue growth was 6.6 percent, putting the latest expansion figure above the operating-profit increase.

Stock remains near its yearly high

IMCD's euro price was EUR 2.72 below its 52-week high of EUR 105.55, a distance of 2.58 percent, based on the October 15, 2026 market range. The 52-week low stood at EUR 68.14, leaving the stock EUR 34.69, or 50.92 percent, above that level.

The valuation data put IMCD at a market capitalization of EUR 6.1 billion and a price-to-earnings ratio of 26.38 as of October 15, 2026. The dividend yield was 0.02 percent. On the home market, IMCD is listed on Euronext Amsterdam under the symbol IMCD.

November date sets the calendar

GlobeNewswire reported on October 15, 2026 that IMCD will publish its first nine months 2026 results on November 5, 2026 at 7:00 a.m. CET. The company scheduled its analyst conference call for 9:00 a.m. CET the same day.

Trading position for investors

The current price is 1.79 percent below the Tradegate close used for the daily comparison, while the stock remains 2.58 percent below its 52-week high. That combination leaves the next results date as the clearest scheduled test for whether the recent earnings trajectory continues.

IMCD stock was trading at EUR 102.83 at Lang & Schwarz on October 15, 2026 at 3:02 p.m. CEST, 1.79 percent below the Tradegate close of October 14, 2026 at EUR 104.70. The further course of trading is shown by the continuously updated real-time quote of IMCD stock.

IMCD stock facts

  • Company: IMCD N.V.
  • ISIN: NL0010801007
  • Ticker: IMCD
  • Primary exchange: Euronext Amsterdam
  • Price Lang & Schwarz as of October 15, 2026, 3:02 p.m. CEST: EUR 102.83
  • Change versus Tradegate close: minus 1.79 percent
  • Tradegate close October 14, 2026: EUR 104.70
  • Market capitalization: EUR 6.1 billion as of October 15, 2026
  • 52-week range: EUR 68.14-EUR 105.55 as of October 15, 2026
  • Sector / Industry: Basic Materials / Specialty Chemicals
  • Index membership: Dutch ESG AEX index
  • Next earnings date: November 5, 2026

Market context: Market report AEX.

More news and analyses on IMCD stock

Disclaimer...
en | NL0010801007 | IMCD | boerse | 70330633 | bgmi